853
PŘEHLEDOVÉ42522701004388130181216258306358404446
ČLÁNKY88722701003973122176223272
Biomarker4253370100435998158193217252286310
GDF-1575233701004389126152173204
v972337010035
kardiologii10233370100347094131147185201240278294309
E1419922701004170111
|325227010043
10.425553085366983
Santema5235540833365102123156213245
BT,783554083356876
Chan8735540834077109146
MMY,103455408354109143151
Tromp1199554083334986144182
J139655408324
et14345540833456
al.1504554083324759
The15785540833271105
influence169855408314516885122156194225258
of19715540833755
atrial204155408332537488120134
fibrillation219055408317347293108122137168189204241279
on24845540833775
the2573554083225994
levels2681554083154981114129154
of28505540833756
NT-proBNP425654083447794133153189224268302
versus741654083286181107142167
GDF-159236540834084116136165194
in11316540831148
patients1193654083356687101134171191218
with1425654083466182119
heart1558654083346798118141
failure.171365408315476175111131163175
Clin1902654083365064100
Res2016654083326591
Cardiol.2121654083366888124138175189201
2020;2336654083316395128139
109(3):2490654083306094112144160171
331–338.2675654083306291123154185218231
11.425753085366678
Sharma5187540833472104125184216
A,7497540834256
Stevens821754083335488120155193219
SR,1055754083346983
Lucas11537540833370102135161
J133075408325
et13707540833557
al.1443754083334861
Utility151975408345688398113135169
of17037540833958
Growth17767540834567104155180218
Differentiation2009754083466282101135156190229250265297319334372411
Factor-15,2435754083346395119156178198228258270
A272075408342
Marker27777540835587108425854083306485
of5258540833958
Oxidative598854083498096135167189204237271
Stress884854083345576111137164
and10638540833371110
Inflammation,118985408316547188120178236268290305343382395
in15998540831654
Chronic16688540834179100137176191223
Heart19068540834581112134158
Failure:208085408333637893130152186198
Insights229385408316548196134172194222
From2530854083345391149
the2694854083236196
HF-2806854083457899
-ACTION4259540832162101137153201247
Study.687954083335492131163173
JACC8759540832464103141
Heart10329540834479111132157
Fail.120495408332627792105
2017;13249540833468100130139
5(10):1479954083345283115133145
724–734.16399540833569101138170204239252
12.4251053085366884
Bouabdallaoui52410540833573111144183222255270285317356394409
N,94810540834457
Claggett10201054083395486126165199222246
B,128110540833547
Zile13441054083375267102
MR146110540835490
et156610540833356
al.16371054083314659
Growth171110540834365102153178216
differentiation1942105408337527291126147181219240256288309325363401
factor-1523591054083175083107144165185216246
is262010540831440
not26751054083377597
modified278710540835795425115408338537188123162
by60311540834374
sacubitril/valsartan6931154083316496134173189211233248263289322354370396429450475508546
and125411540833775114
is138311540832046
an144411540833775
independent15341154083205897132171206245284318357378
marker192711540836395116147181202
of214511540834261
risk2221115408326426898
in233411540832057
patients24071154083437698113148186208235
with26581154083557193132
heart2805115408342774251254083325378
failure518125408323577287125146180
and71312540833775115
reduced8431254083266099137169203242
ejection11011254083395489122146161199238
fraction:13541254083234679111135150188227239
the160812540832765100
PARADIGM-HF172412540834077113156202218262317340386419
trial.2158125408327486496112125
Eur22981254083387495
J2409125408329
Heart245312540834984116138162
Fail.2631125408337678297110
2018;275612540833974105137149
20(12):4251354083346888119149167179
1701–1709.6201354083346396128161192221254289300
13.4251453085366883
Cotter5231454083407799124157179
G,71714540834457
Voors78914540833672111133160
AA,9641454083418499
Prescott10781454083355690117149186208232
MF132514540835588
et142814540833457
al.15001454083324760
Growth157614540834365102153178216
differentiation1807145408339547493127148182220242257289311326364403
factor22251454083185284108145167
15240714540833464
(GDF-15)248714540831861107140162192222241
in274314540831553
patients2811145408339724251554083223772110131159
admitted59915540833170128143166190224263
for8781554083175576
acute97015540833163101123157
heart114215540833772104125150
failure:1307155408317516681119140174186
results15091554083195480118133155183
from17071554083184077136
the18581554083215994
RELAX-AHF196715540833568100143183203244289321
study.23041554083254886125157167
Eur24871554083316889
J2591155408324
Heart263015540834378110131156
Fail.2801155408332617692104
2015;42516540833468100130141
17(11):5811654083346480112139154166
1133–1143.7621654083346292125161192220251283296
14.4251753085377086
Anand52817540834786119158198
IS,7421754083205367
Kempf82517540834176135175195
T,103617540833948
Rector110017540834177111135173196
TS131217540833873
et140017540834063
al.14791754083385467
Serial15621754083397597113146162
measurement174017540836399132159197219254314350389411
of216717540834363
growth-differentiation224617540834466104156182221244285301322341376398433472494510543566581620660
factor-154251854083185284108145167186217247
in68718540831452
heart75418540833772104125150
failure:919185408318516681119140174187
relation11211854083205469102123139177215
to135118540832158
disease14241854083385379114146172207
severity16471854083256092126148163186220
and188218540833169108
prognosis20051854083386097136174213239254280
in230118540831351
the23681854083205994
Valsartan24771854083356681107141162186219257
Heart274918540834479111132156
Failure425195408332627792130151185
Trial.625195408333506698113126
Circulation.7661954083405576108145161193215230268306319
2010;110119540833468100131144
122(14):12611954083346498116147178196208
1387–1395.14841954083346499132164195225258292304
15.4252053085366883
Sunman52320540833371109166199237
H,77520540834457
Canpolat84820540834073111150189205237259
U,112220540834455
Yorgun11922054083367091130167205
H1413205408344
et147220540833557
al.15442054083324861
Association16202054083416996134167182214236251289327
between19632054083397496150184219258
reverse22362054083215587121143170205
electrical24562054083355085118142163179211244259
remodeling2730205408321551131524252154083387389104142181
and62121540833775115
cardiac7512154083366991129144176208
fibrosis9752154083223978100137164179205
markers119521540836395117147182203230
in144121540831957
patients15142154083447798114149187208236
with17662154083557194132
cardiac19132154083377091129144176209
resynchronization21372154083266087120158191229250287326341370404426441479518
therapy.267021540832765100122155194225235
Turk4252254083336687118
Kardiyol5582254083356990128143175212228
Dern80222540834580102140
Ars.9582254083406289103
2018;107622540833468100131143
46(2):12352254083347089123141153
84–91.140322540833470108142174184
16.4252353085366985
Foley5252354083306884118150
PW,69023540833391101
Stegemann8062354083315285125160218250288326
B,114823540833345
Ng120923540834281
K1306235408332
et135323540833254
al.14232354083294558
Growth149623540834163100151176214
differentiation1725235408336517190124146180218239255287308324362400
factor-1521402354083165082106143165184215245
predicts24012354083365892131146178202230
mortality264623540835694115140173188203226259
and42524540833169107
morbidity54724540835492113151167205219241274
after8362454083294772105126
cardiac9772454083286081118133164196
resynchronization11872454083185278110148179217237274311326354387408423461498
therapy.17002454083195691111144182213222
Eur19372454083306686
Heart203824540834175107127151
J.220424540832234
2009;225224540833265100135147
30(22):24142454083316584117151169180
2749–2757.26092454083316494126163194226258291297
17.4252553085366876
Hindricks5172554083456098137158174206236265
G,79725540834558
Potpara8702554083367395134167188221
T,110725540833342
Dagres116425540834678117139173200
N1379255408345
et144025540833457
al.15122554083324861
2020158825540833569102136
ESC173925540833467108
Guidelines18622554083458398137172187202240275302
for21792554083195779
the22732554083226095
diagnosis23842554083385486125163201228242269
and266825540833270109
management27932554083589042526540833870109144202237275296
of73726540833655
atrial808265408331527489121137
fibrillation960265408316337294109124139172193209247285
developed126026540833873105139155193232268307
in158326540831451
collaboration1650265408330678398130169208230263285300338376
with20422654083496587125
the21832654083215994
European22922654083326889127166202234272
Association25792654083406894133165181213234250288326
of42527540833757
Cardio-Thoracic4972754083407394132147185208238278316338371403418450
Surgery9622754083337091129164185219
(EACTS).11972754083185194133169202221232
Eur14442754083337091
Heart155027540834479111132157
J.172227540832437
2020.177427540833468101135148
18.4252853085366985
Hijazi5252854083435873105135150
Z,69128540833649
Oldgren75528540834662101140161195233
J,100328540832335
Lindback10532854083304583122162195227257
J1325285408323
et136328540833255
al.14332854083304558
The150728540833170105
novel162728540833674106141156
biomarker-based17992854083375290148181202233267288308348381407442482
ABC229628540833975116
(age,24272854083174887122134
biomarkers,25762854083375391149181202233267288316329
clinical425295408331476199114146179195
history)-bleeding6352954083355177100137158192211233273289324359399414452491
risk1141295408319346190
score12472954083245693115149
for14112954083165476
patients15022954083377091107141179201229
with17462954083486486125
atrial1886295408330517389121136
fibrillation:2037295408315327193108124139171193208246284296
a2349295408329
derivation23942954083387394110142175197212250289
and269829540833068107
validation2820295408330634253054083153069101123138176214
study.6553054083264987126158168
Lancet.83830540833265103135169191205
2016;105830540833468100131143
387(10035):121730540833468101118149181217250283301313
2302–2311.154630540833469103136170202237268295305
19.4253153085366780
Esteve-Pastor5193154083295678111142175197233263289311347367
MA,90131540835191104
Rivera-Caravaca10203154083324678111131163184226258278310340372403435
JM,14693154083217487
Roldan15703154083326984122153190
V1774315408332
et182131540833052
al.18873154083284355
Long-termbleeding195631540832864101139160182214235292341356390424462477513551
risk2522315408317315685
prediction26223154083355588127141172195209246283
in42532540831551
‘real49132540839276091106
world’61132540834784104119157170
patients7953254083356788102136173193220
with10293254083476284121
atrial1164325408328497084115130
fibrillation:1308325408314316889104118132163184198235272284
Comparison160632540833772129167199220234259296334
of195432540833452
the20213254083185589
HAS-BLED212532540834080113135171202234278
and241732540832966104
ABC-Bleeding253532540833872112125161175209243282296333371
risk425335408321366190
scores.5303354083235591112145171184
The72933540833068103
Murcia84633540835289110140154186
Atrial1046335408339598095126141
Fibrillation12013354083304483104119133147179200215252290
Project.15053354083335389104138170193206
Thromb17263354083306889125183221
Haemost.196233540834173107164202228250263
2017;22403354083316596124133
117(10):23883354083325987103134165182194
1848–1858.25963354083326298133169199230263296309
20.4253453085367287
Wallentin52734540835889104120154193214229267
L,81034540833145
Lopes87034540833169108144171
RD,10563454083358293
Hanna116434540834477115153185
M1364345408355
et143434540833456
al.15063454083324760
Efficacy1581345408333516886118151183217
and181334540833270109
safety19383454083265978112135168
of212234540833756
apixaban21943454083317186117150189222260
compared246934540833269127166199220254294
with27783454083516689127
warfarin42535540835183105126159180196234
at67435540833456
different746355408340557594128149184222243
levels10053554083175284118134160
of118035540834059
predicted12543554083416397137152184208242281
international15503554083175577111132170203224240278316349364
normalized192935540834078100158191206221250284324
ratio2268355408323567893131
control241535540833370109130151189205
for26353554083215880
stroke27303554083295273111141175
prevention4253654083396094127161199220236274312
in75336540831452
atrial820365408332547591123138
fibrillation.974365408317347394110125140172194209247286299
Circulation.12883654083405577108145161193215230268306320
2013;162336540833468100130141
127(22):17803654083346497113147182200211
2166–2176.20073654083346597132170202233262294308
21.4253753085367082
Connolly52237540834279117155194209225256
SJ,7943754083345870
Ezekowitz8803754083346599129166217233255286
MD,1181375408357103113
Yusuf13103754083377298135155
S1480375408334
et152937540833658
al.16033754083334861
Dabigatran168037540834679118133172205226248281319
versus20143754083336889116153180
warfarin220937540835285106128161182198236
in246037540831654
patients25293754083417495111145183205233
with27773754083526890128
atrial425385408332547591123138
fibrillation.578385408317347395110126141173195210248286300
N893385408345
Engl95338540833270109125
J1093385408324
Med.113238540835590129143
2009;129038540833468104139152
361(12):14583854083346898114145175193205
1139–1151.16783854083346292125163194221251282292
22.4253953085367288
Berg5283954083346991129
DD,67239540834490101
Ruff7883954083347292111
CT,9143954083387483
Jarolim10123954083235576114129144202
P1229395408334
et127839540833355
al.13493954083304558
Performance14233954083336788109147169227259297330363
of180239540833555
the18723954083205893
ABC198139540833975116
Scores211239540833163100122156183
for23103954083175576
Assessing24023954083396793128155182197235274
the26913954083205893
Risk28003954083334975105
of42540540833757
Stroke4974054083355678115146180
or69240540834062
Systemic7694054083356592115149207222254
Embolism103840540833693132171187202228286
and133940540833573112
Bleeding14664054083385489124164179217256
in173740540831856
Patients18084054083387092107141180201229
With20524054083607699137
Atrial22044054083446587102134150
Fibrillation23694054083355089111127142157189211226264303
in268740540831755
ENGAGE27584054083358012442541540834184117
AF-TIMI5574154083417496126142197212
48.7854154083347083
Circulation.8844154083405576107145160192214229267306319
2019;121841540833469100130143
139(6):13774154083346497116149167179
760–771.157241540833466101139171205238247
23.3047553085367388
Esteve-Pastor3150554083386689123155190213250282309332369391
MA,355655408360102116
Rivera-Caravaca3688554083405689123144177200243276297330362395427460
JM,4164554083298498
Shantsila42775540833876108147168196211226259
A455155408346
et46135540833961
al.4690554083375265
Assessing47715540834674100136163189204242281
Bleeding5068554083405691127166182220259
Risk5342554083415783113
in54705540832058
Atrial3047654083426385101134150
Fibrillation3212654083395494116132148163196218234273312
Patients:3540654083417395111146185207236249
Comparing38046540834684143183217238254293333
a415365408337
Bleeding4206654083365288124164180218258
Risk4480654083415784114
Score46106540833871109131166
Based47916540834275102138178
Only49856540835392108141
on51416540834383
Modifiable52396540836110014015617419122426430477540831550
Bleeding3112754083385489124164179217256
Risk3383754083395480110
Factors3508754083366597122159180207
against37317540833474106121159185208
the3955754083246297
HAS-BLED40687540834788122145182214247292
Score.43767540833568104126160172
The45647540833574109
AMADEUS46897540834499141187221264296
Trial.5000754083365368100116129
Thromb5144754083367596133191231
Haemost.5390754083477911430478540835796122146159
2017;32218540833468100130139
117(12):3376854083346291107139169187199
2261–2266.35908540833469103133166197232266301314
24.3047953085367186
Hijazi3148954083466177109138154
Z,33179540834053
Oldgren33859540834965104143164198237
J,36379540832638
Lindback3690954083344987126165198230260
J396695408326
et40079540833658
al.4080954083345062
A415895408343
biomarker-based4216954083395492150183204235269290310350383409444484
risk471595408323386494
score4825954083286097118152
to49939540832360
predict5069954083406296135150182206
death52919540834075107128166
in54739540831654
patients30471054083397293109143181203231
with32931054083506688127
atrial3435105408331537590122138
fibrillation:3588105408317347394110125140172194209247286298
the39011054083226095
ABC401110540834177118
(age,41441054083184988123135
biomarkers,42941054083385492150183204234268290317330
clinical4639105408331476299115146179195
history)48491054083375279102139160194212
death507710540833873104126164
risk5257105408320366292
score.53641054083265895117151163
Eur30471154083336990
Heart315311540834479111132156
J.332511540832436
2018;337711540833468100131143
39(6):35351154083346887120138150
477–485.370011540833567101134170206240252
25.30471253085377591
Kempf315512540834278138179200
T,337212540833949
Bjorklund34381254083425999123155173212252293
E,374812540834054
Olofsson381912540835472112133162190230271
S4107125408339
et416312540834165
al.42441254083395670
Growth-differentiation433112540835174113166193233257299316337357393416451492515531565588605645686
factor-1550331254083256094120159182204236268
improves53181254083218112214518430471354083326794
risk3157135408324406798
stratification32711354083295375109131147166183215249271287326365
in365213540831857
ST-segment37251354083357190117153193252287326348
elevation40901354083375389122155178194232271
myocardial437713540836192131164198220258274307323
infarction.47161354083185676110132164189205243282296
Eur50281354083367395
Heart513913540834883116138163
J.531813540832741
2007;537513540833772109142152
28(23):30471454083346988123158176189
2858–2865.325214540833569104139176209243279314326
26.30471553085367187
Wallentin314915540835687103118153191212228265
L,343015540832943
Lindholm34881554083304583122160199214272
D,377515540834455
Siegbahn38451554083314680120159192230268
A4128155408340
et418315540833254
al.42531554083304558
Biomarkers43261554083344987146178199230264285312
in465415540831350
relation47201554083195368101122138176214
to494915540832057
the50221554083195893
effects51301554083325271105138162190
of533515540833555
ticagrelor5405155408320356710030471654083385993109147169
in323116540831351
comparison329716540832966125164197218233260298336
with36491654083486486125
clopidogrel37891654083294583122138177215254275310325
in412916540831351
non-ST-elevation419616540833574112134166200218255270305338371392408446484
acute469516540833062100123157
coronary48671654083296688125163196217251
syndrome51331654083255796135156193252287
patients54351654083377030471754083223772110131159
managed322117540836193131164203238277
with35141754083546992130
or365917540834162
without37371754083546992130168206229
in-hospital39811754083185679118156183222237260292308
revascularization:43041754083245891123150182220235268289304333367389404442480492
a4812175408335
substudy486217540832664103130153191230262
from51391754083224481139
the52941754083256398
Prospective54071754083396097304718540832665101133157173205240
Randomized330218540833567105145183241256285319359
Platelet36761854083354982103137153188210
Inhibition39011854083145291106145160183198236274
and419118540833169108
Patient43141854083356789104139177198
Outcomes452818540834684107138175233268295
(PLATO)48381854083185485128157203221
trial.5075185408321425890105118
Circulation.52091854083395475106144159192213229267305318
2014;304719540833468100131143
129(3):32051954083346498118151168180
293–303.340119540833468101137169204237249
27.30472053085357079
Wallentin314120540835485100115150187209224261
L,341720540832943
Lindhagen34752054083284481120157189227262299
L,379020540832842
Arnstrom38472054083385997123146167204261
E4124205408329
et416920540833153
al.42372054083294457
Early4309205408330638499131
invasive44552054083125080113139154186220
versus46902054083296384111147173
non-invasive487920540833472110132148185216249275290322356
treatment52502054083194074105127184219256277
in304721540831553
patients31162154083377092108144182204232
with33642154083496588127
non-ST-elevation350721540833574113136168203222259275310343377399415453492
acute401521540833063101124158
coronary41892154083306789127166199220255
syndrome44602154083245797136158195254290
(FRISC-II):47662154083165085101134175189206222242254
15503621540833263
year51152154083296496118
follow-up5249215408316547187125177200239278
of304722540833757
a3120225408333
prospective,31692254083396199127166203236261277310345358
randomised,35432254083215594133172231247274309350363
multicentre392222540835896112136152184219257280302337
study.42752254083265089129161172
Lancet.446322540833266105138172195209
2016;468822540833570102134147
388(10054):485122540833570106126158191227262298316329
1903–1911.519622540833566102136173204235268296307
28.30472353085357288
Wollert315123540835591108123158179204
KC,33712354083327184
Kempf347123540833367125164183
T,367023540833039
Peter37252354083336689122144
T3884235408331
et393023540833255
al.40002354083304558
Prognostic40742354083335491130168207234257272304
value43942354083296278116150
of456023540833554
growth-differentiation46302354083365794145170208231271287307325360381415453475491523544560598636
factor-1552822354083165082106143165185216246
in304724540831553
patients311624540834477100116151190212241
with33732454083557194133
non-ST-elevation352224540834382121144176211230267283319352386408424463502
acute404024540833669108131166
coronary42222454083367395133173206227262
syndrome.450024540833164104144165203262298311
Circulation.48272454083456182114153169202224240279318332
2007;517524540833973110144154
115(8):53452454083396798116151170182
962–971.304725540833470104139175208241252
29.30472653085367285
Widera314826540835975114149170203
C,336626540834154
Pencina343526540833770108140155193226
MJ,36762654083558193
Bobadilla378526540833675114147186201217232264
M4064265408356
et413526540833557
al.42082654083324861
Incremental42842654083165486107141199234272294327342
prognostic46412654083406299139177215242265280312
value49682654083336681119154
of513726540833858
biomarkers52102654083405593151184205236270291318
beyond304727540833974106144183222
the328427540832765101
GRACE340027540834985128168201
(Global36162754083246783121161194210
Registry384127540834176116131157180202236
of409327540834261
Acute417027540834678116138172
Coronary435827540834582104141180212234268
Events)464127540833870104143164192209
score486627540833164101122157
and503827540833775114
high-sensitivity5168275408343589713515818522025828529932233730472854083324770104
cardiac31662854083356889127142174206
troponin33872854083264784124163201216254
T3657285408336
in370828540831856
non-ST-elevation377928540834180118141172206225261277312344377399414452490
acute428528540833567105127161
coronary44622854083347193130169201222256
syndrome.473328540833063101140162199257292304
Clin50532854083435873111
Chem.517928540834482117175188
2013;538228540833872104134145
59(10):30472954083346686117149167179
1497–1505.32412954083356699132164195225259293305
30.30473053085367286
Morrow314830540835290111133169220
DA,33833054083428296
Scirica3494305408330617697112144176
BM,368630540833287100
Karwatowska-Prokopczuk38013054083326586139171193229280307336369391428448485515552591624654692722
E4538305408330
et458330540833153
al.46513054083294457
Effects47233054083304967101134157185
of492330540833453
ranolazine49923054083185088126141173202218255290
on529830540833472
recurrent5384305408318528412230473154083214276114136
cardiovascular31983154083296283121136174206239266298336351383404
events36183154083316398136157185
in381831540831350
patients38843154083366991106141179200228
with41273154083486486125
non-ST-elevation426731540833573112134166200218255270305337370392407445484
acute47663154083296199122155
coronary49373154083296687124163195216250
syndromes:52023154083245796135156193251286313325
the30473254083226095
MERLIN-TIMI315732540835588123156171216239269285340356
36352832540833469
randomized36123254083215492131169227242271306345
trial.3972325408322445991106119
JAMA.410732540832464119161176
2007;429832540833569105137147
297(16):446032540833569102118150181199211
1775–1783.46863254083346498131167198228261295307
31.30473353085366981
Collet31443354083438096111146168
JP,33273354083276368
Thiele34103354083357489124140175
H,360033540834760
Barbato36753354083387192132165186223
E3914335408335
et396433540833759
al.40383354083355063
2020411733540833670103137
ESC427033540833569109
Guidelines43953354083468499138173189204242277303
for47143354083215880
the48093354083256398
management492233540836092130163202237295330368389
of532733540833959
acute540133540833567105304734540832255
coronary31183454083326990127166198219253
syndromes33873454083265998137158195254289315
in371834540831553
patients37863454083407394110144182204232
presenting40333454083396195122157195216232270309
without43573454083516789127166204226
persistent45993454083397596123138164187221259281
ST-segment48953454083336786113148187245280318340
elevation.52503454083355085118150172188226264277
Eur30473554083336990
Heart315335540834479111132156
J.332535540832436
2020.337735540833468101135147
32.30473653085367086
Kahli314836540833366104119134
A,329736540833953
Guenancia336536540834179113151183221253268300
C,368036540833750
Zeller3745365408336698599134155
M3915365408352
et398236540833254
al.40513654083294557
Growth41243654083416299150174212
differentiation4352365408335507089123144178216237252284305321358396
factor-1547643654083164981105141163182213243
(GDF-15)502236540831659104137158189219237
levels52743654083134779113129155
are54443654083295084
associated30473754083325885123156171203225258298
with33603754083547092130
cardiac35063754083346788127142174206
and372737540833573112
renal38553754083245896128144
injury40143754083185671108130164
in419337540831856
patients42643754083427597112147185206234
undergoing451337540834179118153174212251266304343
coronary48713754083357293131169201222256
artery51433754083355681114136170
bypass532837540834273113146173199
grafting30473854083385992111136151189228
with32913854083506688126
cardiopulmonary34333854083316485123138176216254269327365404436457491
bypass.394038540833870110143169196209
PLoS416538540833566103135
One.431538540834786121133
2014;446438540833468100131143
9(8):46223854083345387105117
e105759.47543854083346495129163195228239
33.30473953085367085
Munk314739540835289127157
PS,33193954083336578
Valborgland34123954083336479117156177215230262300338
T,376539540833039
Butt38193954083337093117
N,395139540834255
Larsen40213954083286282109144182
AI.42183954083385366
Response42993954083336894133171210236270
of458439540833554
growth46533954083365693144168206
differentiation4874395408336517089123144178215237252284305320358396
factor-1552853954083164981104141162182212242
to304740540832259
percutaneous31214054083427899130168190223261296335373399
coronary35354054083357294131169202223257
intervention38074054083185678111133167202240261276314353
and417540540833573112
regular43034054083245898135150183204
exercise452240540833869103124155170197232
training.4769405408325467994132147185224237
Scand502240540833668101139178
Cardiovasc52154054083447698136151189221254280312
J.304741540832437
2011;309941540833468100128136
45(1):32504154083346785116131143
27–32.340841540833467100132165177
Získejte284811301765690137196256288333393
také7008113017642103163222
nové9458113017663125181240
aktuální12088113017658117162228289322388421
informace1652811301762895136198240339400447508
a21838113017657
kredity2263811301765798159223256301358
v26448113017654
rámci27218113017639100199245278
celoživotního30228113017643104136199249281338399444510543609672
vzdělávání37178113017653104168229261323378438504536
➜432581160216134
https://online.solen.cz4482811301761161612062713183523924334955625946276937547868338969289891056108911361187
Rádi26259210423164309462539
vám85759210423138283519
pomáháme14315921042315730654268884699112261371
v285759210423138
on-line305159210423151309398475550709852
vzdělávání395959210423138262415559636782913105812161292
2388364670435153307
on-line4386885017060124161192223288346
kurzů8066885017058121162212275
a11046885017059
kongresů11856885017058117181243284342388451
7200232272300435153307460613
účastníků23917647017063108170215259323354412474
160239864670435153307460
přednášek23746885017063104162224289348393452509
134073272300435153307460613
vydaných5417647017055114174234298351394458
certikátů10227647017045103145191222290348409451514